Literature DB >> 1733634

Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection.

R J Klaassen1, R Goldschmeding, K M Dolman, A B Vlekke, H M Weigel, J K Eeftinck Schattenkerk, J W Mulder, M L Westedt, A E von dem Borne.   

Abstract

Antibodies against cytoplasmic antigens of neutrophils, producing perinuclear (p-ANCA) as well as cytoplasmic staining with central accentuation (c-ANCA), have been described in non-HIV-infected patients with specific pathology such as glomerulonephritis and vasculitis. Here, we report on a patient with a vasculitis-like syndrome and a positive ANCA-test who appeared to be infected by HIV. Further analysis revealed that ANCA, p-ANCA as well as c-ANCA without central accentuation can be demonstrated in the serum of HIV+ individuals. In a cross-sectional study on individuals in different stages of HIV infection, we found that the occurrence of ANCA was limited to the symptomatic stages of HIV infection: p-ANCA was found in one out of 10 ARC patients and in two out of 11 AIDS patients with malignancies (AIDS-MAL), but not in AIDS patients with opportunistic infections (AIDS-OI). c-ANCA was found in four of the ARC patients, in two of the 14 AIDS-OI patients and in two AIDS-MAL patients. The presence of ANCA was not related to the degree of hypergammaglobulinaemia nor to specific symptomatology. ANCA containing sera from HIV+ individuals did not react with HEp2 cells nor with cytoplasmic antigens of lymphocytes, natural killer (NK) cells or eosinophils. Five out of the 11 (two p-ANCA and three c-ANCA) sera reacted weakly with cytoplasmic antigens of monocytes. All sera reacted with karyoplasts but not with cytoplasts prepared from neutrophils. These results suggest that HIV-ANCA might be directed against myeloid cell-specific granule constituents. However, sandwich-ELISAs with MoAbs against granule antigens that are frequently the target antigens of ANCA in HIV- individuals were negative. Also immunoprecipitation and immunoblotting, using lysates of neutrophil granules, did not allow further identification of the target antigens of HIV-ANCA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733634      PMCID: PMC1554226          DOI: 10.1111/j.1365-2249.1992.tb06408.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

Review 1.  Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis.

Authors:  J W Tervaert; R Goldschmeding; J D Elema; M van der Giessen; M G Huitema; G K van der Hem; T H The; A E von dem Borne; C G Kallenberg
Journal:  Kidney Int       Date:  1990-02       Impact factor: 10.612

2.  Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.

Authors:  H C Lane; J M Depper; W C Greene; G Whalen; T A Waldmann; A S Fauci
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

Review 3.  Immunopathogenesis of the acquired immunodeficiency syndrome.

Authors:  D L Bowen; H C Lane; A S Fauci
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

4.  Infection of monocyte/macrophages by human T lymphotropic virus type III.

Authors:  D D Ho; T R Rota; M S Hirsch
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

5.  Purification and cryopreservation of phagocytes from human blood.

Authors:  D Roos; M de Boer
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

6.  Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?

Authors:  D J Davies; J E Moran; J F Niall; G B Ryan
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

7.  Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection.

Authors:  M F Murphy; P Metcalfe; A H Waters; C A Carne; I V Weller; D C Linch; A Smith
Journal:  Br J Haematol       Date:  1987-07       Impact factor: 6.998

8.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

9.  Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus.

Authors:  J L Ziegler; D P Stites
Journal:  Clin Immunol Immunopathol       Date:  1986-12

10.  Functional activity of enucleated human polymorphonuclear leukocytes.

Authors:  D Roos; A A Voetman; L J Meerhof
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

View more
  21 in total

1.  Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC).

Authors:  J Sobajima; S Ozaki; H Uesugi; F Osakada; H Shirakawa; M Yoshida; K Nakao
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  Anticytokeratins are a potential source of false-positive indirect immunofluorescence assays for C-ANCA.

Authors:  J Streicher; B Fabian; K Herkner; H Pointner; P M Bayer
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

3.  Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection.

Authors:  O A Cornely; S Hauschild; C Weise; E Csernok; W L Gross; B Salzberger; G Fätkenheuer; V Diehl; M Schrappe
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

Review 4.  ANCA in diseases other than systemic vasculitis.

Authors:  H H Peter; D Metzger; A Rump; E Röther
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

5.  Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody.

Authors:  D J Pudifin; J Duursma; V Gathiram; T F Jackson
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  Anti-proteinase 3 antibodies, their characterization and disease associations.

Authors:  J G Jennings; L Chang; J A Savige
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

7.  Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.

Authors:  Anupa Kamat; Petronela Ancuta; Richard S Blumberg; Dana Gabuzda
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

Review 8.  HIV-mediated B-lymphocyte activation and lymphomagenesis.

Authors:  J G Monroe; L E Silberstein
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  A novel specificity of anticytoplasmic autoantibodies directed against eosinophil peroxidase.

Authors:  K M Dolman; I Damsma; A T Tool; A Sonnenberg; A E von dem Borne; R Goldschmeding
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.